Sunday, November 17, 2024
- 10:30AM-12:30PM
-
Abstract Number: 1594
Response to Mepolizumab Therapy in a Single-center Cohort of Eosinophilic Granulomatosis with Polyangiitis Patients: Characterization of Cytokine/Chemokine Pattern and Phenotypic Stratification
Vasculitis – ANCA-Associated Poster II- 10:30AM-12:30PM
-
Abstract Number: 1501
Retrospective Cohort Study Identifying Pulmonary Complications in a Cohort of Patients with Systemic Lupus Erythematosus
SLE – Diagnosis, Manifestations, & Outcomes Poster II- 10:30AM-12:30PM
-
Abstract Number: 0947
REX-7117 Is a Highly Potent and Selective Oral STAT3 Inhibitor That Demonstrated Potential Efficacy and Safety Differentiation versus JAK/TYK2 Targeting in Preclinical Models of Inflammatory Arthritis
Rheumatoid Arthritis – Animal Models Poster- 10:30AM-12:30PM
-
Abstract Number: 1235
Rheum to Grow: Supporting Young Adults with Childhood-Onset Rheumatic Disease in Their Transition to Adult Care
Patient Outcomes, Preferences, & Attitudes Poster II- 10:30AM-12:30PM
-
Abstract Number: 1115
Rheumatic Disease Patients: Assessment of Hydroxychloroquine’s Effects on QTc Intervals with Weight Based Dosing (RAISE-QT) Study
Miscellaneous Rheumatic & Inflammatory Diseases Poster II- 10:30AM-12:30PM
-
Abstract Number: 1324
Rheumatoid Arthritis Associated Interstitial Lung Disease – Patient Perceptions and Recommendations
RA – Diagnosis, Manifestations, & Outcomes Poster II- 10:30AM-12:30PM
-
Abstract Number: 1252
Rheuminating About Drugs, Sex, and Alcohol? Assessing the Informational Needs of Adolescents and Young Adults with Rheumatic Disease
Patient Outcomes, Preferences, & Attitudes Poster II- 10:30AM-12:30PM
-
Abstract Number: 1086
Risk Factors Associated with Loss to Follow-up in a Prospective Gout Cohort
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 1093
Risk of Dementia in Patients with Gout: Potential Impact of Survival Bias
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 1439
Risk of Hip and Spine Fractures in Axial Spondyloarthritis Is Associated with Treatment Class
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster II- 10:30AM-12:30PM
-
Abstract Number: 1336
Risk of Malignancy Under the Treatments with Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: An Analysis Using Japanese Health Insurance Database
RA – Diagnosis, Manifestations, & Outcomes Poster II- 10:30AM-12:30PM
-
Abstract Number: 1401
Risk of Malignancy with TNF-α Inhibitors in Patients with Rheumatoid Arthritis
RA – Treatment Poster II- 10:30AM-12:30PM
-
Abstract Number: 1102
Risk of Mortality and Major Cardiovascular-Kidney Outcomes in Patients with Tophaceous versus Non-Tophaceous Gout
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II- 10:30AM-12:30PM
-
Abstract Number: 1127
Risk of Ocular Inflammatory Conditions in Patients with Autoimmune Diseases: A Retrospective Study Using the National Inpatient Sample